⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AAPG News
Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Announces Global Registrational Phase III Study of Olverembatinib in First-Line Treatment of Ph+ ALL Cleared by US FDA and EMA
globenewswire.com
AAPG
Ascentage Pharma to Host Webcast Highlighting Key Data from ASH 2025
globenewswire.com
AAPG
Ascentage Pharma to Host Webcast Highlighting Key Data from ASH 2025
globenewswire.com
AAPG
Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Nature’s Signal Transduction and Targeted Therapy
globenewswire.com
AAPG
Ascentage Pharma to Participate in Three Upcoming Investor Conferences in December 2025
globenewswire.com
AAPG